Improving Injectable Orthobiologics Reporting Guidelines Adherence: Response

Abstract

Get full access to this article

View all access options for this article.

References

Murray

Chahla

Safran

, et al. International expert consensus on a cell therapy communication tool: DOSES. J Bone Joint Surg Am. 2019;101(10):904-911.

Murray

Geeslin

Goudie

Petrigliano

LaPrade

. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809-819.

Oudelaar

Peerbooms

Huis

‘t Veld

Vochteloo

AJH

. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med. 2019;47(2):479-487.

Paget

LDA

Bierma-Zeinstra

SMA

Goedegebuure

, et al. Platelet-Rich plasma Injection Management for Ankle osteoarthritis study (PRIMA): protocol of a Dutch multicentre, stratified, block-randomised, double-blind, placebo-controlled trial. BMJ Open. 2019;9(10):e030961.

Paget

LDA

Reurink

de Vos

R-J

, et al. Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial. JAMA. 2021;326(16):1595-1605.

Paget

LDA

Reurink

de Vos

R-J

, et al. Platelet-rich plasma injections for the treatment of ankle osteoarthritis. Am J Sports Med. 2023;51(10):2625-2634.

Reurink

Goudswaard

Moen

, et al. Rationale, secondary outcome scores and 1-year follow-up of a randomised trial of platelet-rich plasma injections in acute hamstring muscle injury: the Dutch Hamstring Injection Therapy study. Br J Sports Med. 2015;49(18):1206-1212.